UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement

Journal of clinical pharmacology, 2005-05, Vol.45 (5), p.555-565

2005

Volltextzugriff (PDF)

Joint bayesian network meta-analysis for event counts and hazards – comparison of methods and implementations

Value in health, 2014-05, Vol.17 (3), p.A205-A205

2014

Volltextzugriff (PDF)

Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I

Journal of thrombosis and haemostasis, 2004-09, Vol.2 (9), p.1573-1580

2004

Volltextzugriff (PDF)

1236 MECHANISMS OF ISOLATED UNCONJUGATED HYPERBILIRUBINEMIA INDUCED BY THE HCV NS3/4A PROTEASE INHIBITOR BI201335

Journal of hepatology, 2011-03, Vol.54, p.S488-S488

2011

Volltextzugriff (PDF)

1185 CHARACTERIZATION OF HCV NS3 VARIANTS THAT EMERGED DURING VIROLOGIC BREAKTHROUGH AND RELAPSE FROM BI 201335 PHASE II SILEN-C2 STUDY IN PEGIFN/RBV TREATMENT-EXPERIENCED PATIENTS

Journal of hepatology, 2012-04, Vol.56, p.S469-S469

2012

Volltextzugriff (PDF)

PRM142 - Joint bayesian network meta-analysis for event counts and hazards – comparison of methods and implementations

Value in health, 2014-05, Vol.17 (3), p.A205-A205

2014

Volltextzugriff (PDF)

Dabigatran With or Without Concomitant Aspirin Compared With Warfarin Alone in Patients With Nonvalvular Atrial Fibrillation (PETRO Study)

The American journal of cardiology, 2007-11, Vol.100 (9), p.1419-1426

2007

Volltextzugriff (PDF)

60 SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION

Journal of hepatology, 2011-03, Vol.54, p.S27-S27

2011

Volltextzugriff (PDF)

Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients

Gastroenterology (New York, N.Y. 1943), 2004-11, Vol.127 (5), p.1347-1355

2004

Volltextzugriff (PDF)

Effect of hospitalisation on liver enzymes in healthy subjects

European journal of clinical pharmacology, 2000-07, Vol.56 (4), p.329-333

2000

Volltextzugriff (PDF)

Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C

Hepatology (Baltimore, Md.), 2005-04, Vol.41 (4), p.832-835

2005

Volltextzugriff (PDF)

1054 SAFETY, PHARMACOKINETICS AND ANTIVIRAL EFFECT OF BI 207127, A NOVEL HCV RNA POLYMERASE INHIBITOR, AFTER 5 DAYS ORAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C

Journal of hepatology, 2009, Vol.50, p.S383-S384

2009

Volltextzugriff (PDF)

An open-label study of the pharmacokinetics and pharmacodynamics of dabigatran etexilate 150 mg once daily in Caucasian patients with moderate renal impairment undergoing primary unilateral elective total knee or hip replacement surgery

Thrombosis research, 2016-08, Vol.144, p.158-164

2016

Volltextzugriff (PDF)

[586] SAFETY, PHARMACOKINETICS AND ANTIVIRAL EFFECT OF BILB1941, A NOVEL HCV RNA POLYMERASE INHIBITOR, AFTER 5 DAYS ORAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C

Journal of hepatology, 2007, Vol.46, p.S222-S222

2007

Volltextzugriff (PDF)

Pharmacokinetics and tolerability of meloxicam after i.m. administration

British journal of clinical pharmacology, 1996-02, Vol.41 (2), p.135-139

1996

Volltextzugriff (PDF)

Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation A phase II study

European heart journal, 2000-12, Vol.21 (24), p.2042-2055

2000

Volltextzugriff (PDF)

Effect of Food on the Pharmacokinetics of Meloxicam after Oral Administration

Clinical drug investigation, 1995-05, Vol.9 (5), p.270-276

1995

Volltextzugriff (PDF)

Discussion of a current publication on the effect of garlic on atherosclerosis

Studies in health technology and informatics, 2000, Vol.77, p.73

2000

Volltextzugriff (PDF)

Dipyridamole alone or combined with low‐dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo [see comments]

British journal of clinical pharmacology, 1990-08, Vol.30 (2), p.179-186

1990

Volltextzugriff (PDF)

Long-term efficacy and safety of Pimobendan in moderate heart failure: A double-blind parallel 6-month comparison with enalapril

European heart journal, 1994-07, Vol.15 (7), p.947-956

1994

Volltextzugriff (PDF)

Meloxicam pharmacokinetics in renal impairment

British journal of clinical pharmacology, 1997, Vol.43 (1), p.35-40

1997

Volltextzugriff (PDF)

Pharmacokinetics of meloxicam in patients with end-stage renal failure on haemodialysis : a comparison with healthy volunteers

European journal of clinical pharmacology, 1996, Vol.51 (3-4), p.309-313

1996

Volltextzugriff (PDF)

Pharmacokinetics of Meloxicam in Patients with Hepatic Cirrhosis in Comparison with Healthy Volunteers

Clinical drug investigation, 1996-02, Vol.11 (2), p.97-107

1996

Volltextzugriff (PDF)

67 Hepatitis C viral kinetics in chronically infected patients treated with the serine protease inhibitor BILN 2061

Journal of hepatology, 2004, Vol.40, p.24-25

2004

Volltextzugriff (PDF)

Interaction of Meloxicam with Cimetidine, Maalox, or Aspirin

Journal of clinical pharmacology, 1996-01, Vol.36 (1), p.79-84

1996

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(39)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement

Joint bayesian network meta-analysis for event counts and hazards – comparison of methods and implementations

Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I

1236 MECHANISMS OF ISOLATED UNCONJUGATED HYPERBILIRUBINEMIA INDUCED BY THE HCV NS3/4A PROTEASE INHIBITOR BI201335

1185 CHARACTERIZATION OF HCV NS3 VARIANTS THAT EMERGED DURING VIROLOGIC BREAKTHROUGH AND RELAPSE FROM BI 201335 PHASE II SILEN-C2 STUDY IN PEGIFN/RBV TREATMENT-EXPERIENCED PATIENTS

PRM142 - Joint bayesian network meta-analysis for event counts and hazards – comparison of methods and implementations

Dabigatran With or Without Concomitant Aspirin Compared With Warfarin Alone in Patients With Nonvalvular Atrial Fibrillation (PETRO Study)

60 SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION

Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients

Effect of hospitalisation on liver enzymes in healthy subjects

Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C

1054 SAFETY, PHARMACOKINETICS AND ANTIVIRAL EFFECT OF BI 207127, A NOVEL HCV RNA POLYMERASE INHIBITOR, AFTER 5 DAYS ORAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C

An open-label study of the pharmacokinetics and pharmacodynamics of dabigatran etexilate 150 mg once daily in Caucasian patients with moderate renal impairment undergoing primary unilateral elective total knee or hip replacement surgery

[586] SAFETY, PHARMACOKINETICS AND ANTIVIRAL EFFECT OF BILB1941, A NOVEL HCV RNA POLYMERASE INHIBITOR, AFTER 5 DAYS ORAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C

Pharmacokinetics and tolerability of meloxicam after i.m. administration

Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation A phase II study

Effect of Food on the Pharmacokinetics of Meloxicam after Oral Administration

Discussion of a current publication on the effect of garlic on atherosclerosis

Dipyridamole alone or combined with low‐dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo [see comments]

Long-term efficacy and safety of Pimobendan in moderate heart failure: A double-blind parallel 6-month comparison with enalapril

Meloxicam pharmacokinetics in renal impairment

Pharmacokinetics of meloxicam in patients with end-stage renal failure on haemodialysis : a comparison with healthy volunteers

Pharmacokinetics of Meloxicam in Patients with Hepatic Cirrhosis in Comparison with Healthy Volunteers

67 Hepatitis C viral kinetics in chronically infected patients treated with the serine protease inhibitor BILN 2061

Interaction of Meloxicam with Cimetidine, Maalox, or Aspirin

Suchergebnisse filtern